NCT07428486 2026-02-23
A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
M.D. Anderson Cancer Center
Affiliated Hospital to Academy of Military Medical Sciences
First Affiliated Hospital Xi'an Jiaotong University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd